FDA Inspection 719383 — Robert Boissoneault Oncology Institute
The FDA completed an inspection of Robert Boissoneault Oncology Institute on Apr 12, 2011 in Ocala, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 12, 2011
- Fiscal Year
- 2011
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Ocala, FL (United States)